Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca M Buffa

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Nature Medicine|August 9, 2011
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonizationManav Korpal, Brian J Ell, Francesca M Buffa, et al.
The Journal of Clinical Investigation|January 5, 2012
Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progressionJun Yang, Oliver Staples, Luke W Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2016
Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonistSusana Frago, Ryan D Nicholls, Madeleine Strickland, et al.
Cancer Research|April 6, 2007
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancersStuart C Winter, Francesca M Buffa, Priyamal Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2013
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancerAmanda Eustace, Navin Mani, Paul N Span, et al.
Cell Death & Disease|June 28, 2022
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiationChristos E Zois, Anne M Hendriks, Syed Haider, et al.
Cancer Research|November 29, 2017
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS DefenseMarina Pajic, Danielle Froio, Sheridan Daly, et al.
Genes & Development|January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanomaPaola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast CancerHarriet E Gee, Francesca M Buffa, Adrian L Harris, et al.
Ebiomedicine|July 16, 2024
Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictorsEnric Domingo, Sanjay Rathee, Andrew Blake, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Nature Medicine|August 9, 2011
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonizationManav Korpal, Brian J Ell, Francesca M Buffa, et al.
The Journal of Clinical Investigation|January 5, 2012
Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progressionJun Yang, Oliver Staples, Luke W Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2016
Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonistSusana Frago, Ryan D Nicholls, Madeleine Strickland, et al.
Cancer Research|April 6, 2007
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancersStuart C Winter, Francesca M Buffa, Priyamal Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2013
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancerAmanda Eustace, Navin Mani, Paul N Span, et al.
Cell Death & Disease|June 28, 2022
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiationChristos E Zois, Anne M Hendriks, Syed Haider, et al.
Cancer Research|November 29, 2017
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS DefenseMarina Pajic, Danielle Froio, Sheridan Daly, et al.
Genes & Development|January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanomaPaola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast CancerHarriet E Gee, Francesca M Buffa, Adrian L Harris, et al.
Ebiomedicine|July 16, 2024
Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictorsEnric Domingo, Sanjay Rathee, Andrew Blake, et al.
Pageof 11